Skip to main navigation

Register Now | ProSleep 2023 Users Conference | August 10-12, 2023 | San Francisco, CA

US

How It Works
The Results
FAQ
Why Sleep Apnea

Healthcare Providers

Overview
News Releases

Events

Presentations
Stock Quote & Chart

Historic Price Lookup
Documents & Charters

Board of Directors

Management

Committee Composition
SEC Filings
Investor FAQs

Email Alerts

Contact Investor Relations

News Releases

Year

Mar 21, 2023

ProSomnus® Receives Patent Allowance Covering Automated Manufacturing Process for Company’s Novel Precision Sleep Apnea Medical Devices

Mar 16, 2023

ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023

Mar 10, 2023

ProSomnus® Announces Acceptance of Abstract at European Respiratory Society and European Sleep Research Society’s Sleep and Breathing 2023 Conference

Mar 01, 2023

ProSomnus to Present at Two Upcoming Investor Conferences in March 2023

Mar 01, 2023

ProSomnus® Appoints Brian Dow as Chief Financial Officer

Feb 01, 2023

ProSomnus® Provides Business Update and Preliminary 2022 Revenue Guidance

Jan 26, 2023

ProSomnus® Announces Acceptance of Abstract for Oral Presentation at Prestigious American Thoracic Society 2023 International Conference

For More
Information

Email us at Investors@ProSomnus.com

Patients

How ProSomnus Works

Find a Provider

Healthcare Providers

Getting Started

Instructions for Use

Video Resources

Our Company

About ProSomnus

Investor Relations

United States

Facebook Instagram Youtube LinkedIn